Holen Sie sich die Stockscreener-App
6.91
0.14%
0.010
Vorhandelsmarkt:
7.09
0.18
+2.60%
Schlusskurs vom Vortag:
$6.90
Offen:
$6.83
24-Stunden-Volumen:
418.69K
Relative Volume:
2.88
Marktkapitalisierung:
$229.80M
Einnahmen:
$59.40M
Nettoeinkommen (Verlust:
$-8.66M
KGV:
-18.82
EPS:
-0.3672
Netto-Cashflow:
$-18.93M
1W Leistung:
-7.87%
1M Leistung:
-20.57%
6M Leistung:
-4.03%
1J Leistung:
+5.66%
1-Tages-Spanne:
$6.56
$7.04
1-Wochen-Bereich:
$6.56
$7.69
52-Wochen-Spanne:
$5.51
$9.555
Journey Medical Corp Stock (DERM) Company Profile
Firmenname
Journey Medical Corp
Sektor
Telefon
480-434-6670
Adresse
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Compare DERM vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DERM
Journey Medical Corp
|
6.91 | 229.80M | 59.40M | -8.66M | -18.93M | -0.3672 |
TAK
Takeda Pharmaceutical Co Adr
|
18.04 | 56.99B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
115.93 | 48.94B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.70 | 43.30B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.14 | 33.94B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
531.82 | 23.31B | 3.18B | 1.33B | 1.04B | 27.90 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-07-30 | Fortgesetzt | B. Riley Securities | Buy |
| 2024-08-22 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-06-28 | Fortgesetzt | ROTH MKM | Buy |
| 2021-12-07 | Eingeleitet | B. Riley Securities | Buy |
Journey Medical Corp Aktie (DERM) Neueste Nachrichten
Journey Medical Corp stock faces key test ahead of Q4 2025 earnings release on March 25, 2026 - AD HOC NEWS
Journey Medical Corp (DERM) Q4 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus
Journey Medical Corp expected to post a loss of 6 cents a shareEarnings Preview - TradingView
Pullback Watch: Is Journey Medical Corporation undervalued by DCF analysisWeekly Investment Recap & Capital Protection Trading Alerts - baoquankhu1.vn
Danone Sets New Sustainability Targets with Second Phase of Impact Journey - Food & Beverage Outlook
Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026 - The Manila Times
WallabyPhenox Restructures Debt and Accelerates Global Growth - The Manila Times
Off The Hook Yachts Expands Mid-Atlantic Presence with Strategic Waterfront Hub to Increase Inventory Velocity and Margin Capture - The Manila Times
Siemens Healthineers Launches Brain Health Research Portfolio with First Biomarker Assays Now Available - The Manila Times
GSI Technology Concludes Strategic Alternatives Review - The Manila Times
Dermatology drug seller Journey Medical to detail 2025 results on Mar. 25 - Stock Titan
Journey Medical (DERM) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
TENX PE Ratio & Valuation, Is TENX Overvalued - Intellectia AI
DERM Stock Price, Quote & Chart | JOURNEY MEDICAL CORP (NASDAQ:DERM) - ChartMill
Rally Mode: Will Journey Medical Corporation benefit from sector rotationJuly 2025 Macro Moves & Entry Point Confirmation Alerts - baoquankhu1.vn
Journey Medical (NASDAQ:DERM) Shares Down 3.5%What's Next? - MarketBeat
Analysts Offer Insights on Healthcare Companies: ClearPoint Neuro (CLPT) and Journey Medical Corp (DERM) - The Globe and Mail
10 Best Travel Insurance Companies For 2026 - Forbes
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
DERM PE Ratio & Valuation, Is DERM Overvalued - Intellectia AI
Journey Medical (DERM) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
After Menkes drug approval, Fortress moves to cash in $205M voucher - Stock Titan
Support Test: Will RLX Technology Inc Depositary Receipt stock hit new highs in YEARJuly 2025 Outlook & Community Verified Watchlist Alerts - baoquankhu1.vn
Why ORGO stock attracts high net worth investorsNew Guidance & Stock Portfolio Risk Control - mfd.ru
US Market Wrap: Does Senseonics Holdings Inc have declining or rising EPSQuarterly Growth Report & Community Trade Idea Sharing Platform - baoquankhu1.vn
Analyst Calls: Will Safety Shot Inc outperform the market in YEARJuly 2025 Opening Moves & Daily Profit Focused Stock Screening - baoquankhu1.vn
What’s the RSI of RVYL stockWeekly Trend Recap & Smart Swing Trading Techniques - mfd.ru
How buybacks impact GMAB stock valueQuarterly Portfolio Review & AI Driven Stock Price Forecasts - mfd.ru
DERM Financials: Income Statement, Balance Sheet & Cash Flow | Journey Medical Corp - Stock Titan
DERM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
DERM Should I Buy - Intellectia AI
Gates Industrial (NYSE:GTES) Sets New 52-Week High Following Earnings Beat - Defense World
Journey Medical Corporation (NASDAQ:DERM) Receives $12.17 Consensus Target Price from Brokerages - Defense World
Buyout Rumor: Can Journey Medical Corporation be recession proofJuly 2025 Chart Watch & High Accuracy Swing Trade Signals - baoquankhu1.vn
Insurer Seeks To Cap Coverage In $3M Medical Transport Row - Law360
Insurer Seeks To Cap Coverage In $3M Medical Transit Row - Law360
Essex Investment Management Co. LLC Acquires 125,818 Shares of Journey Medical Corporation $DERM - MarketBeat
Tetracyclines Market is Poised to Garner Valuation of USD 5.63 Billion by 2035 | Astute Analytica - GlobeNewswire Inc.
Journey Medical Corporation (NASDAQ:DERM) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Journey Medical (NASDAQ:DERM) Shares Down 3.7%Here's What Happened - MarketBeat
Patient journey goes digital at Ewha Womans Seoul Hospital - Healthcare IT News
Palmer Township woman’s 20-year journey from cancer survivor to heart health advocate - WFMZ.com
B.Riley reiterates Buy rating on Journey Medical stock, maintains $12 target - Investing.com Nigeria
B.Riley reiterates Buy rating on Journey Medical stock, maintains $12 target By Investing.com - Investing.com South Africa
Will Journey Medical Corporation benefit from geopolitical trendsPortfolio Update Summary & Growth Oriented Trading Recommendations - mfd.ru
Value Recap: Can Journey Medical Corporation reach all time highs this year - baoquankhu1.vn
Risk Analysis: Is DUKPRA impacted by rising ratesMarket Risk Report & Community Supported Trade Ideas - baoquankhu1.vn
CVS Health Corp.: How a Pharmacy Giant Is Rebooting Itself as a Healthcare Platform - AD HOC NEWS
Journey Medical Corp entered into sales agreement to offer and sell up to 3.75 million shares of common stock - marketscreener.com
Journey Medical Corp Entered Into Sales Agreement To Offer And Sell Up To 3.75 Million Shares Of Common Stock - TradingView
Journey Medical: Emrosi Is Winning, But The Stock Hasn't Noticed - Seeking Alpha
Finanzdaten der Journey Medical Corp-Aktie (DERM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):